IGFBP2 Recombinant Antibody, Biotin Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61716r-biotin-100uL |
| Product Name | IGFBP2 Recombinant Antibody, Biotin Conjugated |
| Applications |
WB
IHC-P
IHC-F
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Biotin |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human IGFBP2 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C for 12 months. |
| Target | |
| Gene ID | 3485 |
| Swiss Prot | P18065 |
| Subcellular location | Secreted |
| Synonyms | BP2; IBP2; IGF BP53; IGFBP2; IGFBP53. |
| Background | Inhibits IGF-mediated growth and developmental rates. IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. |
| Application Dilution | |
| WB | 1:500-2000 |
| IHC-P | IHC-P1:50-200 |
| IHC-F | IHC-F1:50-200 |
Frequently asked questions
Which applications is IGFBP2 Recombinant Antibody, Biotin Conjugated (bsm-61716R-Biotin) validated for, and at what dilution?
bsm-61716R-Biotin is validated for WB(WB) (1:500-2000); IHC-P(IHC-P) (1:50-200); IHC-F(IHC-F) (1:50-200). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does IGFBP2 Recombinant Antibody, Biotin Conjugated (bsm-61716R-Biotin) react with?
Tested reactivity: Human.
How should bsm-61716R-Biotin be stored?
Store at -20°C for 12 months. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise IGFBP2 Recombinant Antibody, Biotin Conjugated (bsm-61716R-Biotin)?
KLH conjugated synthetic peptide derived from human IGFBP2